Vident Investment Advisory’s Teladoc Health TDOC Stock Holding History

Vident Investment Advisory’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,913	Closed	-$580K	–	940
2023 Q2	$580K	Buy	22,913 +2,919	+15%	+$73.5K	0.02%	643
2023 Q1	$518K	Buy	19,994 +7,313	+58%	+$196K	0.02%	769
2022 Q4	$300K	Buy	+12,681	New	+$342K	0.01%	888
2022 Q2	–	Sell	-7,285	Closed	-$526K	–	1371
2022 Q1	$526K	Sell	7,285 -1,990	-21%	-$143K	0.01%	914
2021 Q4	$852K	Buy	9,275 +834	+10%	+$99.7K	0.02%	766
2021 Q3	$1.07M	Sell	8,441 -3,613	-30%	-$526K	0.03%	654
2021 Q2	$2M	Buy	12,054 +719	+6%	+$117K	0.06%	409
2021 Q1	$2.06M	Buy	11,335 +564	+5%	+$131K	0.07%	364
2020 Q4	$2.15M	Buy	10,771 +2,941	+38%	+$598K	0.09%	244
2020 Q3	$1.72M	Sell	7,830 -1,479	-16%	-$313K	0.09%	284
2020 Q2	$1.78M	Buy	+9,309	New	+$1.63M	0.09%	232

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vident Investment Advisory's TDOC Position: Q3 2023 in Review

Vident Investment Advisory sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 22,913 shares — an estimated $580K sold.

Vident Investment Advisory first reported a position in TDOC in Q2 2020 and held it in 11 quarters. The position peaked at $2.15M in Q4 2020. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

Vident Investment Advisory reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
Vident Investment Advisory sold 22,913 Teladoc Health shares in Q3 2023, an estimated $580K.
Vident Investment Advisory first reported a position in Teladoc Health in Q2 2020 and held it in 11 quarters.
Vident Investment Advisory's Teladoc Health position peaked at $2.15M in Q4 2020.
436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.